Market Overview:
The global spinal cord stimulator (SCS) systems market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to factors such as the increasing prevalence of chronic pain, technological advancements in SCS devices, and rising demand for minimally invasive surgeries. Based on type, the global spinal cord stimulator (SCS) systems market is segmented into rechargeable and non-rechargeable devices. The rechargeable segment is expected to grow at a higher CAGR than the non-rechargeable segment during the forecast period. This can be attributed to the growing preference for rechargeable devices among patients owing to their longer battery life and ease of use. Based on application, the global spinal cord stimulator (SCS) systems market is divided into failed back surgery syndrome (FBSS), complex regional pain syndrome (CRPS), chronic pain, and other applications.
Product Definition:
A spinal cord stimulator (SCS) system is a device that sends electrical current to the spinal cord to help control pain. The electrical current can be adjusted, so that it blocks or reduces pain signals from reaching the brain.
Rechargeable:
A rechargeable battery is used in spinal cord stimulators. It is an electronic device that generates electrical energy and can be recharged from a standard USB port. The amount of current needed to charge the battery depends on the model of SCS system being used. A small number of models require 1 amp, while others may require 2 or 3 amp charging units.
Non-Rechargeable:
Non-rechargeable batteries are used in spinal cord stimulator (SCS) systems. SCS is a medical device that helps patients suffering from chronic pain to feel less pain by delivering mild electrical impulses to the skin overlying the painful area. The system comprises of an implantable pulse generator and lead wires which are connected to electrodes placed on the skin overlying spinal cord.
Application Insights:
The chronic pain segment dominated the global market in 2017 owing to the increasing prevalence of various types of chronic pain disorders. According to a study published by NCBI, around 300 million people across the globe suffer from chronic pain every year. The same study also states that around 60% of these patients have suffered from some kind of physical trauma at some point in their life which may lead to spinal cord stimulation as an alternative treatment option for them.
The other application segment includes conditions such as failed back surgery syndrome, complex regional pain syndrome and others which are less prevalent compared to abovementioned applications but still worth mentioning due to high treatment costs and extensive research for diagnosis & treatments involved.
Regional Analysis:
North America dominated the global market in 2017. The presence of well-developed healthcare infrastructure, high adoption rate of technologically advanced devices, and rising number of spinal cord stimulators for chronic pain management are some factors driving the regional market. In addition, increasing cases of chronic pain due to trauma & amphetamines is expected to drive demand for SCS systems in North America over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising incidences of neuropathic pain and other forms of chronic pain that lead patients towards seeking medical assistance. Moreover, favorable government initiatives coupled with increasing awareness about alternatives such as Spinal Cord Stimulators (SCS) are also contributing towards regional growth.
Growth Factors:
- Increasing incidence of chronic pain: The global spinal cord stimulator (SCS) systems market is expected to grow at a CAGR of 7.5% during the forecast period due to the increasing incidence of chronic pain. SCS therapy is used for the treatment of various types of chronic pain, such as neuropathic pain, failed back surgery syndrome, and complex regional pain syndrome.
- Growing demand for minimally invasive procedures: The growth in the spinal cord stimulator (SCS) systems market can also be attributed to the growing demand for minimally invasive procedures. Minimally invasive surgeries are less traumatic and result in shorter hospital stays and faster recoveries than traditional open surgeries. This has led to an increase in their adoption over traditional surgical techniques.
- Rising geriatric population: The global population aged 65 years or above is expected to reach 1 billion by 2030, which will drive the demand for SCS therapy as this population is more susceptible to developing chronic conditions that can be treated with this technology..
Scope Of The Report
Report Attributes
Report Details
Report Title
Spinal Cord Stimulator (SCS) Systems Market Research Report
By Type
Rechargeable, Non-Rechargeable
By Application
Failed Back Surgery Syndrome, Complex Regional Pain Syndrome, Chronic Pain, Other
By Companies
Medtronic, Boston Scientific, Abbott (St. Jude Medical), Nevro, Nuvectra
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
247
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Spinal Cord Stimulator (SCS) Systems Market Report Segments:
The global Spinal Cord Stimulator (SCS) Systems market is segmented on the basis of:
Types
Rechargeable, Non-Rechargeable
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Failed Back Surgery Syndrome, Complex Regional Pain Syndrome, Chronic Pain, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medtronic
- Boston Scientific
- Abbott (St. Jude Medical)
- Nevro
- Nuvectra
Highlights of The Spinal Cord Stimulator (SCS) Systems Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Rechargeable
- Non-Rechargeable
- By Application:
- Failed Back Surgery Syndrome
- Complex Regional Pain Syndrome
- Chronic Pain
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Spinal Cord Stimulator (SCS) Systems Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A spinal cord stimulator (SCS) is a medical device that uses electrical stimulation to treat conditions such as chronic pain, spasticity, and other neurological disorders. SCS systems are placed under the skin on the back or chest of the patient and deliver electrical current through electrodes to specific areas of the spinal cord. The devices have been shown to be effective in treating certain conditions, but there is still some research needed in this area.
Some of the major companies in the spinal cord stimulator (scs) systems market are Medtronic, Boston Scientific, Abbott (St. Jude Medical), Nevro, Nuvectra.
The spinal cord stimulator (scs) systems market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Spinal Cord Stimulator (SCS) Systems Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Spinal Cord Stimulator (SCS) Systems Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Spinal Cord Stimulator (SCS) Systems Market - Supply Chain
4.5. Global Spinal Cord Stimulator (SCS) Systems Market Forecast
4.5.1. Spinal Cord Stimulator (SCS) Systems Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Spinal Cord Stimulator (SCS) Systems Market Size (000 Units) and Y-o-Y Growth
4.5.3. Spinal Cord Stimulator (SCS) Systems Market Absolute $ Opportunity
5. Global Spinal Cord Stimulator (SCS) Systems Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Spinal Cord Stimulator (SCS) Systems Market Size and Volume Forecast by Type
5.3.1. Rechargeable
5.3.2. Non-Rechargeable
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Spinal Cord Stimulator (SCS) Systems Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Spinal Cord Stimulator (SCS) Systems Market Size and Volume Forecast by Application
6.3.1. Failed Back Surgery Syndrome
6.3.2. Complex Regional Pain Syndrome
6.3.3. Chronic Pain
6.3.4. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Spinal Cord Stimulator (SCS) Systems Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Spinal Cord Stimulator (SCS) Systems Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Spinal Cord Stimulator (SCS) Systems Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Spinal Cord Stimulator (SCS) Systems Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Spinal Cord Stimulator (SCS) Systems Demand Share Forecast, 2019-2026
9. North America Spinal Cord Stimulator (SCS) Systems Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Spinal Cord Stimulator (SCS) Systems Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Spinal Cord Stimulator (SCS) Systems Market Size and Volume Forecast by Application
9.4.1. Failed Back Surgery Syndrome
9.4.2. Complex Regional Pain Syndrome
9.4.3. Chronic Pain
9.4.4. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Spinal Cord Stimulator (SCS) Systems Market Size and Volume Forecast by Type
9.7.1. Rechargeable
9.7.2. Non-Rechargeable
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Spinal Cord Stimulator (SCS) Systems Demand Share Forecast, 2019-2026
10. Latin America Spinal Cord Stimulator (SCS) Systems Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Spinal Cord Stimulator (SCS) Systems Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Spinal Cord Stimulator (SCS) Systems Market Size and Volume Forecast by Application
10.4.1. Failed Back Surgery Syndrome
10.4.2. Complex Regional Pain Syndrome
10.4.3. Chronic Pain
10.4.4. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Spinal Cord Stimulator (SCS) Systems Market Size and Volume Forecast by Type
10.7.1. Rechargeable
10.7.2. Non-Rechargeable
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Spinal Cord Stimulator (SCS) Systems Demand Share Forecast, 2019-2026
11. Europe Spinal Cord Stimulator (SCS) Systems Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Spinal Cord Stimulator (SCS) Systems Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Spinal Cord Stimulator (SCS) Systems Market Size and Volume Forecast by Application
11.4.1. Failed Back Surgery Syndrome
11.4.2. Complex Regional Pain Syndrome
11.4.3. Chronic Pain
11.4.4. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Spinal Cord Stimulator (SCS) Systems Market Size and Volume Forecast by Type
11.7.1. Rechargeable
11.7.2. Non-Rechargeable
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Spinal Cord Stimulator (SCS) Systems Demand Share, 2019-2026
12. Asia Pacific Spinal Cord Stimulator (SCS) Systems Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Spinal Cord Stimulator (SCS) Systems Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Spinal Cord Stimulator (SCS) Systems Market Size and Volume Forecast by Application
12.4.1. Failed Back Surgery Syndrome
12.4.2. Complex Regional Pain Syndrome
12.4.3. Chronic Pain
12.4.4. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Spinal Cord Stimulator (SCS) Systems Market Size and Volume Forecast by Type
12.7.1. Rechargeable
12.7.2. Non-Rechargeable
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Spinal Cord Stimulator (SCS) Systems Demand Share, 2019-2026
13. Middle East & Africa Spinal Cord Stimulator (SCS) Systems Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Spinal Cord Stimulator (SCS) Systems Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Spinal Cord Stimulator (SCS) Systems Market Size and Volume Forecast by Application
13.4.1. Failed Back Surgery Syndrome
13.4.2. Complex Regional Pain Syndrome
13.4.3. Chronic Pain
13.4.4. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Spinal Cord Stimulator (SCS) Systems Market Size and Volume Forecast by Type
13.7.1. Rechargeable
13.7.2. Non-Rechargeable
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Spinal Cord Stimulator (SCS) Systems Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Spinal Cord Stimulator (SCS) Systems Market: Market Share Analysis
14.2. Spinal Cord Stimulator (SCS) Systems Distributors and Customers
14.3. Spinal Cord Stimulator (SCS) Systems Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Medtronic
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Boston Scientific
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Abbott (St. Jude Medical)
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Nevro
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Nuvectra
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook